Kite, a Gilead company, specializes in creating innovative cancer drugs. They focus on CAR-T (Chimeric Antigen Receptor) cell treatments, available in Belgium for the treatment of patients with specific types of lymphomas.
To update stakeholders on CAR-T advancements, Kite has launched the Cell Therapy Hub, a portal dedicated to healthcare professionals.
Find out more
BE-YES-0081